INSIGHTS ON SOLID DOSE MANUFACTURING

• Single-Use Containment And Oral Solid Dosage (OSD)

  Flexible single-use containment systems achieve sub-microgram exposure levels while eliminating cleaning validation downtime for high-potency oral solid dose manufacturing.

• GLP-1 OSD Chemical Synthesis Workflow

  Enhance containment and process reliability in oral GLP-1 synthesis. Discover how integrated single-use assemblies and automated fluidics safeguard chemical purity during scale-up.

• Exploring The Future Of Tablet Compression Across Emerging Industries

  Many growing industries face universal tablet compression challenges, demanding better tooling, tighter process control, and more integrated data to ensure product consistency and reliable scale-up.

• Layer By Layer: 3D Screen Printing And The Future Of Drug Development

  3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.

• Reconstitutable Powder Filling System For Global MedTech Client

  9/3/2026

  Custom automated powder dosing platforms streamline dual-powder aseptic device assembly, achieving high-speed precision and robust containment control

• Rational Design And Material-sparing Strategies For Enabled Intermediates And Drug Products

  9/9/2026

  A material-sparing strategy integrating formulation mapping, lab-scale spray drying, and compact screening can accelerate risk identification and inform first-round tablet formulation decisions for poorly soluble APIs.

• Ask Us Anything: Jillian Sheeran On Emerging Reactor Technologies

  7/23/2026

  Jillian Sheeran, Associate Director of Engineering at Snapdragon Chemistry, on how automation, feedback control, and machine learning are changing reactor design — with real-time monitoring that lets a process run continuously while the data comes to you.

• 5 Hidden Risks In Early-Phase OSD Formulation Development

  8/31/2026

  Early formulation decisions in OSD development carry risks that may not surface until later stages, when the cost of course correction is significantly higher.

• Predicting Drug-Loading Limits In Tablet Formulations

  7/15/2026

  Learn how predictive percolation modeling identified critical drug-loading limits of ~20% for crystalline API and ~15% for SDD forms, cutting tablet formulation trial-and-error significantly.